Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 46.72M | $ 6M | 12.84% |
3/31/2025 | $ 45.62M | $ 4.6M | 10.08% |
12/31/2024 | $ 45.1M | $ 3.76M | 8.33% |
9/30/2024 | $ 44.45M | $ 3.81M | 8.57% |
6/30/2024 | $ 41.86M | $ 1.32M | 3.16% |
3/31/2024 | $ 43.05M | $ 960.35K | 2.23% |
12/31/2023 | $ 43.81M | $ 978.74K | 2.23% |
9/30/2023 | $ 44.55M | $ 1.99M | 4.47% |
6/30/2023 | $ 44.01M | $ 1.45M | 3.3% |
3/31/2023 | $ 43.12M | $ 3.1M | 7.18% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for IMMUCELL CORP is calculated as follows: CashnEq [ $ 5.32M ] / Assets [ $ 39.99M ]
(=) Cash to Assets [ 13.3% ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |